
Pfizer’s Bold Bet on Liquid Biopsy: Aiming for Breakthroughs Amid Market Uncertainty
Pfizer partners with Guardant Health to advance in the liquid biopsy technology space, aiming to revolutionize oncology care. This non-invasive cancer detection method offers improved patient comfort and potential for more frequent and accurate monitoring. Pfizer’s stock recently increased by 1.59%, though